It falls within the J-code category, which CMS maintains for drugs administered other than orally, typically by injection or infusion
Common topical side effects and what causes them Let's start with what most people experience
The same case report documented biological age reduction and telomere length increase, with the patient's biological age decreasing by 7.9 years (from 75.93 to 68.03) and telomere length increasing from 6.45 to 6.59 kb over one year of treatment
Neuroscience and Behavioral Physiology, 36(1), 8591
Cagrilintide: What the Evidence Actually Shows The pivotal standalone human dataset for cagrilintide is a multicentre, randomised, double-blind, placebo- and active-controlled, dose-finding Phase 2 trial in people with overweight or obesity